Special Issue on Research in Leukemia

Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader group of diseases affecting the blood, bone marrow, and lymphoid system, which are all known as hematological neoplasms. Leukemia is a treatable disease. Most treatments involve chemotherapy, medical radiation therapy, or hormone treatments. The rate of curedepends on the type of leukemia as well as the age of the patient. Children are more likely to be permanently cured than adults. Even when a complete cure is unlikely, most people with a chronic leukemia and many people with an acute leukemia can be successfully treated for years.

Leukemia can affect people at any age. In 2000 approximately 256,000 children and adults around the world developed some form of leukemia, and 209,000 died from it. About 90% of all leukemias are diagnosed in adults.

In this special issue, we intend to invite front-line researchers and authors to submit original research and review articles on exploring Research in Leukemia.

Authors should read over the journal’s Authors’ Guidelines carefully before submission, Prospective authors should submit an electronic copy of their complete manuscript through the journal Paper Submission System.

According to the following timetable:

Please kindly notice that the “Special Issue’’ under your manuscript title is supposed to be specified and the research field “Special Issue — Research in Leukemia” should be chosen during your submission.

Guest Editors：

Prof. Ricardo Forastiero,  Favaloro University, Argentina

For further questions or inquiries

Please contact Editorial Assistant at

ojbd@scirp.org